Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
Inroads made on curing hepatitis C patients, but inadequate funding remains an issue
+News
In print
Summer Hiatus
Inroads made on curing hepatitis C patients, but inadequate funding remains an issue
Monday 30 December 2019, 09:00 AM

In New Zealand, patients with hepatitis C typically contract the life-threatening virus through intravenous drug use or from dirty tattoo needles
We are on our summer break and the editorial office is closed until 13 January. We hope you enjoy this article which is part of Summer Hiatus, an eclectic mix from our news and clinical archives throughout the year, The Conversation and other publications we share content with. Please note the comment function has been turned off while we are away. Happy reading
GPs are feeling good about the success of Maviret for hepatitis C patients, but still find they’re not funded enough to do the work required.
Ten
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.